About: Amarin Corporation

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Amarin Corporation Goto Sponge NotDistinct Permalink

An Entity of Type : yago:SocialGroup107950920, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/c/4NidLVyEYh

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa (AMR-101) received FDA-approval, competing against GlaxoSmithKline's Lovaza.

Attributes	Values
rdf:type	Thing company schema:Organization dul:Agent dul:SocialPerson agent wikidata:Q24229398 Organization Business enterprise yago:WikicatBiotechnologyCompaniesOfTheUnitedStates yago:WikicatCompaniesBasedInGreaterNewYorkArea yago:WikicatCompaniesBasedInSomersetCounty,NewJersey yago:WikicatCompaniesListedOnNASDAQ yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity organisation yago:SocialGroup107950920
rdfs:label	Amarin Corporation (en) Amarin (de)
rdfs:comment	Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa (AMR-101) received FDA-approval, competing against GlaxoSmithKline's Lovaza. (en) Amarin Corporation ist ein irisch-amerikanischer Pharmakonzern mit Sitz in Dublin und Bridgewater. Das im Jahr 1993 gegründete Unternehmen ist auf die Herstellung und Vermarktung von Medikamenten zur Behandlung von Herz-Kreislauf-Erkrankungen spezialisiert und brachte mit Vascepa (US) 2013 ein entsprechendes Präparat auf den nordamerikanischen Markt. (de)
foaf:name	Amarin Corporation (en)
foaf:homepage	http://www.amarincorp.com
name	Amarin Corporation (en)
foaf:depiction
location	Dublin Bridgewater, New Jersey
dct:subject	Biotechnology companies of the United States Companies listed on the Nasdaq Pharmaceutical companies based in New Jersey Companies based in Somerset County, New Jersey
Wikipage page ID	36552790 (xsd:integer)
Wikipage revision ID	1097307204 (xsd:integer)
Link from a Wikipage to another Wikipage	Cytokine storm Public company Neurodegeneration Biotechnology companies of the United States Companies listed on the Nasdaq Colorectal cancer Chief executive officer Omega-3 fatty acid GlaxoSmithKline Committee for Medicinal Products for Human Use Triglyceride COVID-19 Pharmaceutical companies based in New Jersey Dublin Dublin, Ireland Alzheimer's disease European Commission Food and Drug Administration Non-alcoholic fatty liver disease Cardiovascular disease Biotech and pharmaceutical companies in the New York metropolitan area Hikma Pharmaceuticals Companies based in Somerset County, New Jersey Biopharmaceutical Biotechnology Diabetes dbr:C-reactive_protein Lovaza Bridgewater, New Jersey Petition for certiorari US Supreme Court dbr:Ester_Neurosciences_Limited dbr:Vaskepa
Link from a Wikipage to an external page	https://www.nasdaq.com/market-activity/stocks/amrn http://www.amarincorp.com https://www.sec.gov/cgi-bin/browse-edgar%3Faction=getcompany&CIK=AMRN https://finance.yahoo.com/quote/AMRN%3Fp=AMRN
sameAs	Amarin Corporation Amarin Corporation Amarin Corporation Amarin Corporation Amarin Corporation Amarin Corporation
dbp:wikiPageUsesTemplate	dbt:Increase dbt:Infobox_company dbt:More_citations_needed dbt:Reflist dbt:Short_description
thumbnail	wiki-commons:Special:FilePath/Amarin_logo.jpg?width=300
foundation	1993 (xsd:integer)
industry	Biotechnology
location	Bridgewater, New Jersey Dublin, Ireland (en)
logo	Amarin logo.jpg (en)
num employees	~1000 (en)
products	Vascepa (en)
revenue	6.141E8 (usDollar)
traded as	NASDAQ:AMRN (en)
type	Public company
has abstract	Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa (AMR-101) received FDA-approval, competing against GlaxoSmithKline's Lovaza. (en) Amarin Corporation ist ein irisch-amerikanischer Pharmakonzern mit Sitz in Dublin und Bridgewater. Das im Jahr 1993 gegründete Unternehmen ist auf die Herstellung und Vermarktung von Medikamenten zur Behandlung von Herz-Kreislauf-Erkrankungen spezialisiert und brachte mit Vascepa (US) 2013 ein entsprechendes Präparat auf den nordamerikanischen Markt. (de)

Faceted Search & Find service v1.17_git147 as of Sep 06 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3332 as of Dec 5 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 56 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software